Literature DB >> 18610752

The biological role of chondroitin sulfate in cancer and chondroitin-based anticancer agents.

Athanasia P Asimakopoulou1, Achilleas D Theocharis, George N Tzanakakis, Nikos K Karamanos.   

Abstract

Chondroitin sulfate proteoglycans (CSPGs) such as versican accumulate in tumor stroma and play a key role in tumor growth and invasion. The high expression of CSPGs in fast growing tissues and cells is correlated with chondroitin sulfate (CS) chains and the sulfation pattern. The negatively charged CS chains interact with a large number of ligands and receptors and activate signalling pathways which stimulate tumor growth. However, the role of chondroitin sulfate in cancer promotion seems to be controversial, as recent studies support the use of modified CS as a potent anticancer agent. In this review, the biological roles of CSPGs in cancer and the anticancer effects of modified CS are presented and discussed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18610752

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  32 in total

1.  Humanized chondroitinase ABC sensitizes glioblastoma cells to temozolomide.

Authors:  Alena Cristina Jaime-Ramirez; Nina Dmitrieva; Ji Young Yoo; Yeshavanth Banasavadi-Siddegowda; Jianying Zhang; Theresa Relation; Chelsea Bolyard; Jeffrey Wojton; Balveen Kaur
Journal:  J Gene Med       Date:  2017-03       Impact factor: 4.565

2.  Chondroitin sulfate as a molecular portal that preferentially mediates the apoptotic killing of tumor cells by penetratin-directed mitochondria-disrupting peptides.

Authors:  Hao Yang; Shan Liu; Huawei Cai; Lin Wan; Shengfu Li; Youping Li; Jingqiu Cheng; Xiaofeng Lu
Journal:  J Biol Chem       Date:  2010-05-18       Impact factor: 5.157

3.  MDA-MB-231 breast cancer cell viability, motility and matrix adhesion are regulated by a complex interplay of heparan sulfate, chondroitin-/dermatan sulfate and hyaluronan biosynthesis.

Authors:  Manuela Viola; Kathrin Brüggemann; Evgenia Karousou; Ilaria Caon; Elena Caravà; Davide Vigetti; Burkhard Greve; Christian Stock; Giancarlo De Luca; Alberto Passi; Martin Götte
Journal:  Glycoconj J       Date:  2016-10-15       Impact factor: 2.916

4.  Chondroitin sulphate and heparan sulphate sulphation motifs and their proteoglycans are involved in articular cartilage formation during human foetal knee joint development.

Authors:  James Melrose; Marc D Isaacs; Susan M Smith; Clare E Hughes; Christopher B Little; Bruce Caterson; Anthony J Hayes
Journal:  Histochem Cell Biol       Date:  2012-05-23       Impact factor: 4.304

5.  Efficient secretion of biologically active Chondroitinase ABC from mammalian cells in the absence of an N-terminal signal peptide.

Authors:  Michael Klüppel
Journal:  Mol Cell Biochem       Date:  2011-01-07       Impact factor: 3.396

6.  Prognostic impact of chondroitin-4-sulfotransferase CHST11 in ovarian cancer.

Authors:  L Oliveira-Ferrer; A Heßling; F Trillsch; S Mahner; K Milde-Langosch
Journal:  Tumour Biol       Date:  2015-06-18

7.  Increased expression of chondroitin sulphate proteoglycans in rat hepatocellular carcinoma tissues.

Authors:  Xiao-Li Jia; Si-Yuan Li; Shuang-Suo Dang; Yan-An Cheng; Xin Zhang; Wen-Jun Wang; Clare E Hughes; Bruce Caterson
Journal:  World J Gastroenterol       Date:  2012-08-14       Impact factor: 5.742

8.  Chondroitin Sulfate in Solution: Effects of Mono- and Divalent Salts.

Authors:  Ferenc Horkay; Peter J Basser; Anne-Marie Hecht; Erik Geissler
Journal:  Macromolecules       Date:  2012-03-27       Impact factor: 5.985

9.  Changes in composition and sulfation patterns of glycoaminoglycans in renal cell carcinoma.

Authors:  Ebru Ucakturk; Orkun Akman; Xiaojun Sun; Dilek Ertoy Baydar; Anil Dolgun; Fuming Zhang; Robert J Linhardt
Journal:  Glycoconj J       Date:  2015-12-14       Impact factor: 2.916

10.  Identification of chondroitin polymerizing factor (CHPF) as tumor promotor in cholangiocarcinoma through regulating cell proliferation, cell apoptosis and cell migration.

Authors:  Xiaohui Duan; Jianhui Yang; Bo Jiang; Wenbin Duan; Rongguang Wei; Hui Zhang; Xianhai Mao
Journal:  Cell Cycle       Date:  2021-03-02       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.